Value
5.2/10data confidence 67%| Component | Sub-score |
|---|---|
| P/S | 8.3 |
| EV/EBITDA | 3.3 |
| p ocf | 9.3 |
| Analyst target | 4.0 |
- ▸P/OCF: 6.7x (FFO proxy — REITs gated off P/E)
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Alexandria is a life-science office REIT trading at 5.9x operating cash flow with a 7.2% dividend and 25% analyst upside, but revenue is down 11%, the stock is 50% off its high in a downtrend, and 53% of NOI comes from a concentrated tenant base.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
| Pillar | Expectation | Trend |
|---|---|---|
53% of net operating income comes from investment-grade or publicly traded large-cap tenants, above the 40% threshold, and the portfolio is concentrated in life science. Bear case | Tenant concentration declines below 40% or lease renewals stay stable. | ↑Improving |
| CounterInvestment-grade tenants have low default risk, so concentration may be less dangerous than it looks. | ||
The REIT trades at 5.9x price to operating cash flow with FCF yield of 18.4% and a Piotroski F-Score of 8/9, suggesting a deep discount to cash generation. Quality breakdown | Cash flow holds and price rerates toward the analyst target with 8.7% upside. | →Stable |
| CounterReported GAAP net income is negative, and a large January impairment-style loss (EPS -6.35) shows book value can erode. | ||
Revenue declined 11% and growth ranks at the bottom of peers (growth rank 0.0), a sign of weak leasing demand. Growth breakdown | Revenue decline narrows to under 5% and turns positive within 12 months. | →Stable |
| CounterAsset sales and dispositions can shrink revenue while improving balance-sheet quality, so the decline may be deliberate. | ||
Momentum is 2.3 with price below the 200-day average, falling OBV and a death cross, with a 50% drawdown from the 52-week high. Momentum breakdown | Momentum rises above 4.5 and the price reclaims the 200-day average. | ↑Improving |
| CounterA 50% drawdown plus 25% analyst upside may mean the bad news is priced in, setting up a value rebound. | ||
The 7.2% dividend yield is the main return source, but dividend safety scores only 5.8 with declining revenue. Catalyst breakdown | Dividend is maintained at the current rate through the next 12 months. | ↑Improving |
| CounterA high yield after a deep price decline often signals the market expects a cut. | ||
CounterInvestment-grade tenants have low default risk, so concentration may be less dangerous than it looks.
CounterReported GAAP net income is negative, and a large January impairment-style loss (EPS -6.35) shows book value can erode.
CounterAsset sales and dispositions can shrink revenue while improving balance-sheet quality, so the decline may be deliberate.
CounterA 50% drawdown plus 25% analyst upside may mean the bad news is priced in, setting up a value rebound.
CounterA high yield after a deep price decline often signals the market expects a cut.
| Component | Sub-score |
|---|---|
| P/S | 8.3 |
| EV/EBITDA | 3.3 |
| p ocf | 9.3 |
| Analyst target | 4.0 |
| Component | Sub-score |
|---|---|
| ROE | 0.0 |
| ROA | 0.6 |
| Gross margin | 9.5 |
| Op margin | 5.8 |
| Net margin | 0.0 |
| Current ratio | 7.5 |
| FCF quality | 10.0 |
| Moat | 4.8 |
| Rule of 40 | 5.5 |
| Piotroski F | 8.9 |
| Component | Sub-score |
|---|---|
| Rev growth | 0.0 |
| Component | Sub-score |
|---|---|
| RSI | 3.5 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 4.0 |
| Volume | 0.0 |
| Component | Sub-score |
|---|---|
| LLM sentiment | 4.6 |
| Analyst rating | 5.0 |
| Price target | 6.0 |
| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 5.6 |
| notable moves | 7.0 |
| Component | Sub-score |
|---|---|
| value rank | 5.3 |
| quality rank | 0.9 |
| growth rank | 0.0 |
| Component | Sub-score |
|---|---|
| bollinger | 0.0 |
| support resistance | 1.3 |
| 52w position | 1.6 |
| gap | 5.0 |
| Component | Sub-score |
|---|---|
| short interest | 7.1 |
| days to cover | 7.4 |
| volatility | 1.9 |
| put call | 10.0 |
| implied vol | 4.0 |
| max pain risk | 7.0 |
| beta | 6.2 |
| debt equity | 6.7 |
| news risk | 5.5 |
| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 5.6 |
| earnings timing | 5.0 |
| surprise avg | 0.0 |
| dividend safety | 5.8 |
| news activity | 8.0 |
Multiple concerning factors. Consider reducing position.
L4:PATH_F_SELLSetupRecovery — Death cross but MACD improving, RSI 65
EdgeNo clear edge — No clear edge identified
SuitabilitySpeculative — Drawdown -42% (>40% off 52w high)
The F-path SELL output reflects an overall score of 2.6 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Risk (lower is worse) at 6.2) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:-0.5=NEGATIVE, REIT_TENANT_CLIFF:HARD_BLOCK) reinforce the read. Current asymmetry R:R is -0.46 — supplementary context, not the trigger for this path.
The strongest dimensions are Risk (lower is worse) at 6.2, Insider at 5.9, and Momentum at 5.5; the weakest are Growth at 0.0, Technical at 2.0, and Peer rank at 3.9. The V9 engine flagged 2 failed gates with 1 warning, producing an asymmetric reward-to-risk of -0.46 and an engine sizing output of AVOID.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
Trip ifFCF yield falls below 10% from current 18.4% or the Piotroski F-Score falls below 6.
Trip ifShare of NOI from large-cap tenants exceeds 60% from current 53%.
Trip ifRevenue declines more than 15% year over year.
Trip ifMomentum score stays below 2.0 for 2 consecutive months.
Trip ifDividend is cut by more than 25% from the current rate.